Filing status
- Accounts due
- 31 July 2027
- Last accounts
- 31 October 2025
- Conf. stmt due
- 17 October 2027
- Last conf. stmt
- 3 October 2026
Biopharma Futures Ltd
- Incorporated
- 14 October 2020 (6 years)
- Industry
- Management consultancy activities other than financial management (70229)
- Owned by
- Mel Walker
- Accounts type
- Unaudited abridged
- Region
- Greater London
- Address
- Suite 1B1Argyle House NorthsideJoel StreetNorthwood HillsHA6 1NW
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Mel Walker
Individual · Notified 14 October 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
British
Born May 1974 (52)
Holdings 1
Companies where Biopharma Futures Ltd is registered as a person with significant control
Owns 25–50% of shares
Active
Financials
Balance sheet as at 31 October 2025 · unaudited abridged accounts
- Net Assets
- £346,237
- Cash
- £328,181
- Employees
- 1
- Debt Ratio
- 21%
- Current Ratio
- 4.7x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Fixed Assets | £35,578 | £47,102 | £61,467 | £82,690 | |
| Current Assets | £405,298 | £552,701 | £408,919 | £144,948 | |
| Debtors | £25 | ||||
| Cash | £328,181 | £512,330 | £365,094 | £144,923 | £152,205 |
| Creditors (< 1 year) | £85,746 | £200,244 | £153,705 | £50,717 | £68,306 |
| Net Current Assets | £319,552 | £352,457 | £255,214 | £94,231 | |
| Net Assets | £346,237 | £399,559 | £316,681 | £176,921 | £83,899 |
| Shareholder Funds | £346,237 | £399,559 | £316,681 | £176,921 | £83,899 |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →